Pharma solutions
Overview
Body Composition
Cardiometabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
Overview
LiverMultiScan
MRCP+
CoverScan
Cancer
Perspectum Portal
our Research
Overview
Publications
WhitePapers
our company
Overview
Senior Management
Board of Directors
News
Learning Resources
Contact
Careers
Oxford Community Diagnostic Centre
Our Locations
AASLD 2024 - Abstracts
MRI-serum based score accurately identifies liver transplant patients without rejection avoiding need for liver biopsy: a multisite European study
The use of AI-assisted digital pathology in determining the inflammatory burden in liver disease
An automatic tissue folding detection algorithm to aid AI segmentation models
An automatic out of focus detection model for enabling the assessment of liver biopsies
Histological diagnostic tool for detecting and characterising portal tracts in liver disease using Artificial Intelligence
MRCP+ has a role in enhancing detection of high-grade strictures in primary sclerosing cholangitis
Periductal cT1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis
Quantitative MRCP metrics have utility in assessing changes in biliary tree health in PSC patients: a ten-year
Repeatability and reproducibility of PSC-specific biomarkers from quantitative MRCP
A combined imaging and proteomic approach identifies inflammatory response proteins upregulated in MASH: results from the UK Biobank
T1-mapping in the liver: The need for standardization